Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
439
archived clinical trials in
Eating Disorder

Hormone Release and Stomach Disturbances in People With Binge Eating Disorder
Postprandial Cholecystokinin Release and Gastric Emptying in Binge Eating Disorder
Status: Archived
Eating Disorders Clinic, New York State Psychiatric Institute
mi
from
New York, NY
Hormone Release and Stomach Disturbances in People With Binge Eating Disorder
Postprandial Cholecystokinin Release and Gastric Emptying in Binge Eating Disorder
Status: Archived
Updated: 1/1/1970
Eating Disorders Clinic, New York State Psychiatric Institute
mi
from
New York, NY
Serotonin Transporter Concentrations in Women With a History of Anorexia Nervosa
A Positron Emission Tomography Study of the Serotonin Transporter in Weight-Restored Women With Anorexia Nervosa
Status: Archived
New York State Psychiatric Insitute
mi
from
New York, NY
Serotonin Transporter Concentrations in Women With a History of Anorexia Nervosa
A Positron Emission Tomography Study of the Serotonin Transporter in Weight-Restored Women With Anorexia Nervosa
Status: Archived
Updated: 1/1/1970
New York State Psychiatric Insitute
mi
from
New York, NY
Determining the Response to Sipping Beverages Without Swallowing in People With Eating Disorders
Study of Response to the Taste of Beverages That Are Not Swallowed (Sipping and Spitting in Eating Disorders)
Status: Archived
New York State Psychiatric Insitute
mi
from
New York, NY
Determining the Response to Sipping Beverages Without Swallowing in People With Eating Disorders
Study of Response to the Taste of Beverages That Are Not Swallowed (Sipping and Spitting in Eating Disorders)
Status: Archived
Updated: 1/1/1970
New York State Psychiatric Insitute
mi
from
New York, NY
Craving, Binge Eating and Obesity
Placebo-Controlled Trial of Bupropion for the Treatment of Binge Eating Disorder
Status: Archived
Yale University School of Medicine
mi
from
New Haven, CT
Craving, Binge Eating and Obesity
Placebo-Controlled Trial of Bupropion for the Treatment of Binge Eating Disorder
Status: Archived
Updated: 1/1/1970
Yale University School of Medicine
mi
from
New Haven, CT
Nurture: A Program for Mothers With Histories of Disordered Eating
Breaking the Cycle of Risk: Intervention for Mothers With Eating Disorders
Status: Archived
University of North Carolina Chapel Hill
mi
from
Chapel Hill, NC
Nurture: A Program for Mothers With Histories of Disordered Eating
Breaking the Cycle of Risk: Intervention for Mothers With Eating Disorders
Status: Archived
Updated: 1/1/1970
University of North Carolina Chapel Hill
mi
from
Chapel Hill, NC
Testing an Internet-Based Intervention for Preventing Eating Disorders
Preventing Eating Disorders and Reducing Comorbidity
Status: Archived
Stanford university Hospital and Clinics
mi
from
Stanford, CA
Testing an Internet-Based Intervention for Preventing Eating Disorders
Preventing Eating Disorders and Reducing Comorbidity
Status: Archived
Updated: 1/1/1970
Stanford university Hospital and Clinics
mi
from
Stanford, CA
Testing an Internet-Based Intervention for Preventing Eating Disorders
Preventing Eating Disorders and Reducing Comorbidity
Status: Archived
Washington University
mi
from
St. Louis, MO
Testing an Internet-Based Intervention for Preventing Eating Disorders
Preventing Eating Disorders and Reducing Comorbidity
Status: Archived
Updated: 1/1/1970
Washington University
mi
from
St. Louis, MO
ALK33-101: A Study of RDC-0313 (ALKS 33) in Adults With Binge Eating Disorder
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Pilot Study of the Safety and Efficacy of RDC-0313 in Adults With Binge Eating Disorder
Status: Archived
Alkermes' Investigational Study Site
mi
from
Tucson, AZ
ALK33-101: A Study of RDC-0313 (ALKS 33) in Adults With Binge Eating Disorder
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Pilot Study of the Safety and Efficacy of RDC-0313 in Adults With Binge Eating Disorder
Status: Archived
Updated: 1/1/1970
Alkermes' Investigational Study Site
mi
from
Tucson, AZ
ALK33-101: A Study of RDC-0313 (ALKS 33) in Adults With Binge Eating Disorder
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Pilot Study of the Safety and Efficacy of RDC-0313 in Adults With Binge Eating Disorder
Status: Archived
Alkermes' Investigational Study Site
mi
from
Minneapolis, MN
ALK33-101: A Study of RDC-0313 (ALKS 33) in Adults With Binge Eating Disorder
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Pilot Study of the Safety and Efficacy of RDC-0313 in Adults With Binge Eating Disorder
Status: Archived
Updated: 1/1/1970
Alkermes' Investigational Study Site
mi
from
Minneapolis, MN
ALK33-101: A Study of RDC-0313 (ALKS 33) in Adults With Binge Eating Disorder
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Pilot Study of the Safety and Efficacy of RDC-0313 in Adults With Binge Eating Disorder
Status: Archived
Alkermes' Investigational Study Site
mi
from
Manlius, NY
ALK33-101: A Study of RDC-0313 (ALKS 33) in Adults With Binge Eating Disorder
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Pilot Study of the Safety and Efficacy of RDC-0313 in Adults With Binge Eating Disorder
Status: Archived
Updated: 1/1/1970
Alkermes' Investigational Study Site
mi
from
Manlius, NY
ALK33-101: A Study of RDC-0313 (ALKS 33) in Adults With Binge Eating Disorder
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Pilot Study of the Safety and Efficacy of RDC-0313 in Adults With Binge Eating Disorder
Status: Archived
Alkermes' Investigational Study Site
mi
from
Raleigh, NC
ALK33-101: A Study of RDC-0313 (ALKS 33) in Adults With Binge Eating Disorder
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Pilot Study of the Safety and Efficacy of RDC-0313 in Adults With Binge Eating Disorder
Status: Archived
Updated: 1/1/1970
Alkermes' Investigational Study Site
mi
from
Raleigh, NC
ALK33-101: A Study of RDC-0313 (ALKS 33) in Adults With Binge Eating Disorder
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Pilot Study of the Safety and Efficacy of RDC-0313 in Adults With Binge Eating Disorder
Status: Archived
Alkermes' Investigational Study Site
mi
from
Mason, OH
ALK33-101: A Study of RDC-0313 (ALKS 33) in Adults With Binge Eating Disorder
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Pilot Study of the Safety and Efficacy of RDC-0313 in Adults With Binge Eating Disorder
Status: Archived
Updated: 1/1/1970
Alkermes' Investigational Study Site
mi
from
Mason, OH
Effectiveness of Antibiotic Treatment for Reducing Binge Eating and Improving Digestive Function in Bulimia Nervosa
Effects of Erythromycin on Binge Eating and GI Function in Bulimia Nervosa
Status: Enrolling
Updated:  12/31/1969
Eating Disorders Clinic, New York State Psychiatric Institute
mi
from
New York, NY
Effectiveness of Antibiotic Treatment for Reducing Binge Eating and Improving Digestive Function in Bulimia Nervosa
Effects of Erythromycin on Binge Eating and GI Function in Bulimia Nervosa
Status: Enrolling
Updated: 12/31/1969
Eating Disorders Clinic, New York State Psychiatric Institute
mi
from
New York, NY
Click here to add this to my saved trials
An fMRI Study of Self-regulation in Adolescents With Bulimia Nervosa
An fMRI Study of Self-regulation in Adolescents With Bulimia Nervosa
Status: Enrolling
Updated:  12/31/1969
The New York State Psychiatric Institute at Columbia University Medical Center
mi
from
New York, NY
An fMRI Study of Self-regulation in Adolescents With Bulimia Nervosa
An fMRI Study of Self-regulation in Adolescents With Bulimia Nervosa
Status: Enrolling
Updated: 12/31/1969
The New York State Psychiatric Institute at Columbia University Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Guided Self-Help for Binge Eating Disorder
Comparison of Integrative Response Therapy and Cognitive Behavioral Therapy Guided Self-Help for Binge Eating Disorder
Status: Enrolling
Updated:  12/31/1969
Stanford University School of Medicine
mi
from
Stanford, CA
Guided Self-Help for Binge Eating Disorder
Comparison of Integrative Response Therapy and Cognitive Behavioral Therapy Guided Self-Help for Binge Eating Disorder
Status: Enrolling
Updated: 12/31/1969
Stanford University School of Medicine
mi
from
Stanford, CA
Click here to add this to my saved trials
Outcomes of Cognitive Behavioral Therapy (CBT) Interventions Provided by Unlicensed Professionals
Outcomes of Cognitive Behavioral Therapy (CBT) Interventions Provided by Unlicensed Professionals in a General Hospital Setting
Status: Enrolling
Updated:  12/31/1969
Cognitive-Behavioral Therapy and Behavioral Medicine Programs, Massachusetts General Hospital
mi
from
Boston, MA
Outcomes of Cognitive Behavioral Therapy (CBT) Interventions Provided by Unlicensed Professionals
Outcomes of Cognitive Behavioral Therapy (CBT) Interventions Provided by Unlicensed Professionals in a General Hospital Setting
Status: Enrolling
Updated: 12/31/1969
Cognitive-Behavioral Therapy and Behavioral Medicine Programs, Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Effectiveness Trial of a Dissonance-Based Obesity Prevention Program
Effectiveness Trial of a Dissonance-Based Obesity Prevention Program
Status: Enrolling
Updated:  12/31/1969
Oregon State University
mi
from
Corvallis, OR
Effectiveness Trial of a Dissonance-Based Obesity Prevention Program
Effectiveness Trial of a Dissonance-Based Obesity Prevention Program
Status: Enrolling
Updated: 12/31/1969
Oregon State University
mi
from
Corvallis, OR
Click here to add this to my saved trials
Effectiveness Trial of a Dissonance-Based Obesity Prevention Program
Effectiveness Trial of a Dissonance-Based Obesity Prevention Program
Status: Enrolling
Updated:  12/31/1969
Oregon Research Institute
mi
from
Eugene, OR
Effectiveness Trial of a Dissonance-Based Obesity Prevention Program
Effectiveness Trial of a Dissonance-Based Obesity Prevention Program
Status: Enrolling
Updated: 12/31/1969
Oregon Research Institute
mi
from
Eugene, OR
Click here to add this to my saved trials
Effectiveness Trial of a Dissonance-Based Obesity Prevention Program
Effectiveness Trial of a Dissonance-Based Obesity Prevention Program
Status: Enrolling
Updated:  12/31/1969
University of Oregon
mi
from
Eugene, OR
Effectiveness Trial of a Dissonance-Based Obesity Prevention Program
Effectiveness Trial of a Dissonance-Based Obesity Prevention Program
Status: Enrolling
Updated: 12/31/1969
University of Oregon
mi
from
Eugene, OR
Click here to add this to my saved trials
Effectiveness Trial of a Dissonance-Based Obesity Prevention Program
Effectiveness Trial of a Dissonance-Based Obesity Prevention Program
Status: Enrolling
Updated:  12/31/1969
University of Texas at Austin
mi
from
Austin, TX
Effectiveness Trial of a Dissonance-Based Obesity Prevention Program
Effectiveness Trial of a Dissonance-Based Obesity Prevention Program
Status: Enrolling
Updated: 12/31/1969
University of Texas at Austin
mi
from
Austin, TX
Click here to add this to my saved trials
Open Label Extension in Adults With Binge Eating Disorder (BED)
A Phase 3, Multicenter, Open-label, 12 Month Extension Safety and Tolerability Study of SPD489 in the Treatment of Adults With Binge Eating Disorder
Status: Enrolling
Updated:  12/31/1969
Clinical Study Centers, LLC
mi
from
Little Rock, AR
Open Label Extension in Adults With Binge Eating Disorder (BED)
A Phase 3, Multicenter, Open-label, 12 Month Extension Safety and Tolerability Study of SPD489 in the Treatment of Adults With Binge Eating Disorder
Status: Enrolling
Updated: 12/31/1969
Clinical Study Centers, LLC
mi
from
Little Rock, AR
Click here to add this to my saved trials
Open Label Extension in Adults With Binge Eating Disorder (BED)
A Phase 3, Multicenter, Open-label, 12 Month Extension Safety and Tolerability Study of SPD489 in the Treatment of Adults With Binge Eating Disorder
Status: Enrolling
Updated:  12/31/1969
Southwestern Research
mi
from
Beverly Hills, CA
Open Label Extension in Adults With Binge Eating Disorder (BED)
A Phase 3, Multicenter, Open-label, 12 Month Extension Safety and Tolerability Study of SPD489 in the Treatment of Adults With Binge Eating Disorder
Status: Enrolling
Updated: 12/31/1969
Southwestern Research
mi
from
Beverly Hills, CA
Click here to add this to my saved trials
Open Label Extension in Adults With Binge Eating Disorder (BED)
A Phase 3, Multicenter, Open-label, 12 Month Extension Safety and Tolerability Study of SPD489 in the Treatment of Adults With Binge Eating Disorder
Status: Enrolling
Updated:  12/31/1969
Pharmacology Research Institute
mi
from
Newport Beach, CA
Open Label Extension in Adults With Binge Eating Disorder (BED)
A Phase 3, Multicenter, Open-label, 12 Month Extension Safety and Tolerability Study of SPD489 in the Treatment of Adults With Binge Eating Disorder
Status: Enrolling
Updated: 12/31/1969
Pharmacology Research Institute
mi
from
Newport Beach, CA
Click here to add this to my saved trials
Open Label Extension in Adults With Binge Eating Disorder (BED)
A Phase 3, Multicenter, Open-label, 12 Month Extension Safety and Tolerability Study of SPD489 in the Treatment of Adults With Binge Eating Disorder
Status: Enrolling
Updated:  12/31/1969
Scripps Clinical Research Services
mi
from
La Jolla, CA
Open Label Extension in Adults With Binge Eating Disorder (BED)
A Phase 3, Multicenter, Open-label, 12 Month Extension Safety and Tolerability Study of SPD489 in the Treatment of Adults With Binge Eating Disorder
Status: Enrolling
Updated: 12/31/1969
Scripps Clinical Research Services
mi
from
La Jolla, CA
Click here to add this to my saved trials
Open Label Extension in Adults With Binge Eating Disorder (BED)
A Phase 3, Multicenter, Open-label, 12 Month Extension Safety and Tolerability Study of SPD489 in the Treatment of Adults With Binge Eating Disorder
Status: Enrolling
Updated:  12/31/1969
Pacific Research Partners, LLC
mi
from
Oakland, CA
Open Label Extension in Adults With Binge Eating Disorder (BED)
A Phase 3, Multicenter, Open-label, 12 Month Extension Safety and Tolerability Study of SPD489 in the Treatment of Adults With Binge Eating Disorder
Status: Enrolling
Updated: 12/31/1969
Pacific Research Partners, LLC
mi
from
Oakland, CA
Click here to add this to my saved trials
Open Label Extension in Adults With Binge Eating Disorder (BED)
A Phase 3, Multicenter, Open-label, 12 Month Extension Safety and Tolerability Study of SPD489 in the Treatment of Adults With Binge Eating Disorder
Status: Enrolling
Updated:  12/31/1969
Excell Research, Inc.
mi
from
Oceanside, CA
Open Label Extension in Adults With Binge Eating Disorder (BED)
A Phase 3, Multicenter, Open-label, 12 Month Extension Safety and Tolerability Study of SPD489 in the Treatment of Adults With Binge Eating Disorder
Status: Enrolling
Updated: 12/31/1969
Excell Research, Inc.
mi
from
Oceanside, CA
Click here to add this to my saved trials
Open Label Extension in Adults With Binge Eating Disorder (BED)
A Phase 3, Multicenter, Open-label, 12 Month Extension Safety and Tolerability Study of SPD489 in the Treatment of Adults With Binge Eating Disorder
Status: Enrolling
Updated:  12/31/1969
PCSD - Feighner Research
mi
from
San Diego, CA
Open Label Extension in Adults With Binge Eating Disorder (BED)
A Phase 3, Multicenter, Open-label, 12 Month Extension Safety and Tolerability Study of SPD489 in the Treatment of Adults With Binge Eating Disorder
Status: Enrolling
Updated: 12/31/1969
PCSD - Feighner Research
mi
from
San Diego, CA
Click here to add this to my saved trials
Open Label Extension in Adults With Binge Eating Disorder (BED)
A Phase 3, Multicenter, Open-label, 12 Month Extension Safety and Tolerability Study of SPD489 in the Treatment of Adults With Binge Eating Disorder
Status: Enrolling
Updated:  12/31/1969
Radiant Research, Inc.
mi
from
Denver, CO
Open Label Extension in Adults With Binge Eating Disorder (BED)
A Phase 3, Multicenter, Open-label, 12 Month Extension Safety and Tolerability Study of SPD489 in the Treatment of Adults With Binge Eating Disorder
Status: Enrolling
Updated: 12/31/1969
Radiant Research, Inc.
mi
from
Denver, CO
Click here to add this to my saved trials
Open Label Extension in Adults With Binge Eating Disorder (BED)
A Phase 3, Multicenter, Open-label, 12 Month Extension Safety and Tolerability Study of SPD489 in the Treatment of Adults With Binge Eating Disorder
Status: Enrolling
Updated:  12/31/1969
Gulfcoast Clinical Research
mi
from
Fort Myers, FL
Open Label Extension in Adults With Binge Eating Disorder (BED)
A Phase 3, Multicenter, Open-label, 12 Month Extension Safety and Tolerability Study of SPD489 in the Treatment of Adults With Binge Eating Disorder
Status: Enrolling
Updated: 12/31/1969
Gulfcoast Clinical Research
mi
from
Fort Myers, FL
Click here to add this to my saved trials
Open Label Extension in Adults With Binge Eating Disorder (BED)
A Phase 3, Multicenter, Open-label, 12 Month Extension Safety and Tolerability Study of SPD489 in the Treatment of Adults With Binge Eating Disorder
Status: Enrolling
Updated:  12/31/1969
Clinical Neuroscience Solutions, Inc
mi
from
Orlando, FL
Open Label Extension in Adults With Binge Eating Disorder (BED)
A Phase 3, Multicenter, Open-label, 12 Month Extension Safety and Tolerability Study of SPD489 in the Treatment of Adults With Binge Eating Disorder
Status: Enrolling
Updated: 12/31/1969
Clinical Neuroscience Solutions, Inc
mi
from
Orlando, FL
Click here to add this to my saved trials
Open Label Extension in Adults With Binge Eating Disorder (BED)
A Phase 3, Multicenter, Open-label, 12 Month Extension Safety and Tolerability Study of SPD489 in the Treatment of Adults With Binge Eating Disorder
Status: Enrolling
Updated:  12/31/1969
Miami Research Associates
mi
from
South Miami, FL
Open Label Extension in Adults With Binge Eating Disorder (BED)
A Phase 3, Multicenter, Open-label, 12 Month Extension Safety and Tolerability Study of SPD489 in the Treatment of Adults With Binge Eating Disorder
Status: Enrolling
Updated: 12/31/1969
Miami Research Associates
mi
from
South Miami, FL
Click here to add this to my saved trials
Open Label Extension in Adults With Binge Eating Disorder (BED)
A Phase 3, Multicenter, Open-label, 12 Month Extension Safety and Tolerability Study of SPD489 in the Treatment of Adults With Binge Eating Disorder
Status: Enrolling
Updated:  12/31/1969
Atlanta Institute of Medicine and Research
mi
from
Atlanta, GA
Open Label Extension in Adults With Binge Eating Disorder (BED)
A Phase 3, Multicenter, Open-label, 12 Month Extension Safety and Tolerability Study of SPD489 in the Treatment of Adults With Binge Eating Disorder
Status: Enrolling
Updated: 12/31/1969
Atlanta Institute of Medicine and Research
mi
from
Atlanta, GA
Click here to add this to my saved trials
Open Label Extension in Adults With Binge Eating Disorder (BED)
A Phase 3, Multicenter, Open-label, 12 Month Extension Safety and Tolerability Study of SPD489 in the Treatment of Adults With Binge Eating Disorder
Status: Enrolling
Updated:  12/31/1969
Neurotrials Research, Inc.
mi
from
Atlanta, GA
Open Label Extension in Adults With Binge Eating Disorder (BED)
A Phase 3, Multicenter, Open-label, 12 Month Extension Safety and Tolerability Study of SPD489 in the Treatment of Adults With Binge Eating Disorder
Status: Enrolling
Updated: 12/31/1969
Neurotrials Research, Inc.
mi
from
Atlanta, GA
Click here to add this to my saved trials
Open Label Extension in Adults With Binge Eating Disorder (BED)
A Phase 3, Multicenter, Open-label, 12 Month Extension Safety and Tolerability Study of SPD489 in the Treatment of Adults With Binge Eating Disorder
Status: Enrolling
Updated:  12/31/1969
Capstone Clinical Research
mi
from
Libertyville, IL
Open Label Extension in Adults With Binge Eating Disorder (BED)
A Phase 3, Multicenter, Open-label, 12 Month Extension Safety and Tolerability Study of SPD489 in the Treatment of Adults With Binge Eating Disorder
Status: Enrolling
Updated: 12/31/1969
Capstone Clinical Research
mi
from
Libertyville, IL
Click here to add this to my saved trials
Open Label Extension in Adults With Binge Eating Disorder (BED)
A Phase 3, Multicenter, Open-label, 12 Month Extension Safety and Tolerability Study of SPD489 in the Treatment of Adults With Binge Eating Disorder
Status: Enrolling
Updated:  12/31/1969
Baber Research Group
mi
from
Naperville, IL
Open Label Extension in Adults With Binge Eating Disorder (BED)
A Phase 3, Multicenter, Open-label, 12 Month Extension Safety and Tolerability Study of SPD489 in the Treatment of Adults With Binge Eating Disorder
Status: Enrolling
Updated: 12/31/1969
Baber Research Group
mi
from
Naperville, IL
Click here to add this to my saved trials
Open Label Extension in Adults With Binge Eating Disorder (BED)
A Phase 3, Multicenter, Open-label, 12 Month Extension Safety and Tolerability Study of SPD489 in the Treatment of Adults With Binge Eating Disorder
Status: Enrolling
Updated:  12/31/1969
American Medical Research, Inc.
mi
from
Oak Brook, IL
Open Label Extension in Adults With Binge Eating Disorder (BED)
A Phase 3, Multicenter, Open-label, 12 Month Extension Safety and Tolerability Study of SPD489 in the Treatment of Adults With Binge Eating Disorder
Status: Enrolling
Updated: 12/31/1969
American Medical Research, Inc.
mi
from
Oak Brook, IL
Click here to add this to my saved trials
Open Label Extension in Adults With Binge Eating Disorder (BED)
A Phase 3, Multicenter, Open-label, 12 Month Extension Safety and Tolerability Study of SPD489 in the Treatment of Adults With Binge Eating Disorder
Status: Enrolling
Updated:  12/31/1969
Goldpoint Clinical Research
mi
from
Indianapolis, IN
Open Label Extension in Adults With Binge Eating Disorder (BED)
A Phase 3, Multicenter, Open-label, 12 Month Extension Safety and Tolerability Study of SPD489 in the Treatment of Adults With Binge Eating Disorder
Status: Enrolling
Updated: 12/31/1969
Goldpoint Clinical Research
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Open Label Extension in Adults With Binge Eating Disorder (BED)
A Phase 3, Multicenter, Open-label, 12 Month Extension Safety and Tolerability Study of SPD489 in the Treatment of Adults With Binge Eating Disorder
Status: Enrolling
Updated:  12/31/1969
Clinical Trials Technology, Inc
mi
from
Prairie Village, KA
Open Label Extension in Adults With Binge Eating Disorder (BED)
A Phase 3, Multicenter, Open-label, 12 Month Extension Safety and Tolerability Study of SPD489 in the Treatment of Adults With Binge Eating Disorder
Status: Enrolling
Updated: 12/31/1969
Clinical Trials Technology, Inc
mi
from
Prairie Village, KA
Click here to add this to my saved trials
Open Label Extension in Adults With Binge Eating Disorder (BED)
A Phase 3, Multicenter, Open-label, 12 Month Extension Safety and Tolerability Study of SPD489 in the Treatment of Adults With Binge Eating Disorder
Status: Enrolling
Updated:  12/31/1969
Cypress Medical Research Center, LLC
mi
from
Wichita, KA
Open Label Extension in Adults With Binge Eating Disorder (BED)
A Phase 3, Multicenter, Open-label, 12 Month Extension Safety and Tolerability Study of SPD489 in the Treatment of Adults With Binge Eating Disorder
Status: Enrolling
Updated: 12/31/1969
Cypress Medical Research Center, LLC
mi
from
Wichita, KA
Click here to add this to my saved trials
Open Label Extension in Adults With Binge Eating Disorder (BED)
A Phase 3, Multicenter, Open-label, 12 Month Extension Safety and Tolerability Study of SPD489 in the Treatment of Adults With Binge Eating Disorder
Status: Enrolling
Updated:  12/31/1969
Louisana Research Associates, Inc
mi
from
New Orleans, LA
Open Label Extension in Adults With Binge Eating Disorder (BED)
A Phase 3, Multicenter, Open-label, 12 Month Extension Safety and Tolerability Study of SPD489 in the Treatment of Adults With Binge Eating Disorder
Status: Enrolling
Updated: 12/31/1969
Louisana Research Associates, Inc
mi
from
New Orleans, LA
Click here to add this to my saved trials
Open Label Extension in Adults With Binge Eating Disorder (BED)
A Phase 3, Multicenter, Open-label, 12 Month Extension Safety and Tolerability Study of SPD489 in the Treatment of Adults With Binge Eating Disorder
Status: Enrolling
Updated:  12/31/1969
McLean Hospital
mi
from
Belmont, MA
Open Label Extension in Adults With Binge Eating Disorder (BED)
A Phase 3, Multicenter, Open-label, 12 Month Extension Safety and Tolerability Study of SPD489 in the Treatment of Adults With Binge Eating Disorder
Status: Enrolling
Updated: 12/31/1969
McLean Hospital
mi
from
Belmont, MA
Click here to add this to my saved trials
Open Label Extension in Adults With Binge Eating Disorder (BED)
A Phase 3, Multicenter, Open-label, 12 Month Extension Safety and Tolerability Study of SPD489 in the Treatment of Adults With Binge Eating Disorder
Status: Enrolling
Updated:  12/31/1969
Boston Clinical Trials, INC.
mi
from
Boston, MA
Open Label Extension in Adults With Binge Eating Disorder (BED)
A Phase 3, Multicenter, Open-label, 12 Month Extension Safety and Tolerability Study of SPD489 in the Treatment of Adults With Binge Eating Disorder
Status: Enrolling
Updated: 12/31/1969
Boston Clinical Trials, INC.
mi
from
Boston, MA
Click here to add this to my saved trials
Open Label Extension in Adults With Binge Eating Disorder (BED)
A Phase 3, Multicenter, Open-label, 12 Month Extension Safety and Tolerability Study of SPD489 in the Treatment of Adults With Binge Eating Disorder
Status: Enrolling
Updated:  12/31/1969
Rochester Center for Behavioral Medicine
mi
from
Rochester Hills, MI
Open Label Extension in Adults With Binge Eating Disorder (BED)
A Phase 3, Multicenter, Open-label, 12 Month Extension Safety and Tolerability Study of SPD489 in the Treatment of Adults With Binge Eating Disorder
Status: Enrolling
Updated: 12/31/1969
Rochester Center for Behavioral Medicine
mi
from
Rochester Hills, MI
Click here to add this to my saved trials
Open Label Extension in Adults With Binge Eating Disorder (BED)
A Phase 3, Multicenter, Open-label, 12 Month Extension Safety and Tolerability Study of SPD489 in the Treatment of Adults With Binge Eating Disorder
Status: Enrolling
Updated:  12/31/1969
Univ of Minnesota
mi
from
Minneapolis, MN
Open Label Extension in Adults With Binge Eating Disorder (BED)
A Phase 3, Multicenter, Open-label, 12 Month Extension Safety and Tolerability Study of SPD489 in the Treatment of Adults With Binge Eating Disorder
Status: Enrolling
Updated: 12/31/1969
Univ of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Open Label Extension in Adults With Binge Eating Disorder (BED)
A Phase 3, Multicenter, Open-label, 12 Month Extension Safety and Tolerability Study of SPD489 in the Treatment of Adults With Binge Eating Disorder
Status: Enrolling
Updated:  12/31/1969
Robert Lynne Horne, MD
mi
from
Las Vegas, NV
Open Label Extension in Adults With Binge Eating Disorder (BED)
A Phase 3, Multicenter, Open-label, 12 Month Extension Safety and Tolerability Study of SPD489 in the Treatment of Adults With Binge Eating Disorder
Status: Enrolling
Updated: 12/31/1969
Robert Lynne Horne, MD
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Open Label Extension in Adults With Binge Eating Disorder (BED)
A Phase 3, Multicenter, Open-label, 12 Month Extension Safety and Tolerability Study of SPD489 in the Treatment of Adults With Binge Eating Disorder
Status: Enrolling
Updated:  12/31/1969
Center for Psychiatry and Behavioral Medicine, Inc.
mi
from
Las Vegas, NV
Open Label Extension in Adults With Binge Eating Disorder (BED)
A Phase 3, Multicenter, Open-label, 12 Month Extension Safety and Tolerability Study of SPD489 in the Treatment of Adults With Binge Eating Disorder
Status: Enrolling
Updated: 12/31/1969
Center for Psychiatry and Behavioral Medicine, Inc.
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Open Label Extension in Adults With Binge Eating Disorder (BED)
A Phase 3, Multicenter, Open-label, 12 Month Extension Safety and Tolerability Study of SPD489 in the Treatment of Adults With Binge Eating Disorder
Status: Enrolling
Updated:  12/31/1969
Global Medical Institues, LLC
mi
from
Princeton, NJ
Open Label Extension in Adults With Binge Eating Disorder (BED)
A Phase 3, Multicenter, Open-label, 12 Month Extension Safety and Tolerability Study of SPD489 in the Treatment of Adults With Binge Eating Disorder
Status: Enrolling
Updated: 12/31/1969
Global Medical Institues, LLC
mi
from
Princeton, NJ
Click here to add this to my saved trials
Open Label Extension in Adults With Binge Eating Disorder (BED)
A Phase 3, Multicenter, Open-label, 12 Month Extension Safety and Tolerability Study of SPD489 in the Treatment of Adults With Binge Eating Disorder
Status: Enrolling
Updated:  12/31/1969
Pacific Institute for Research and Evaluation
mi
from
Albuquerque, NM
Open Label Extension in Adults With Binge Eating Disorder (BED)
A Phase 3, Multicenter, Open-label, 12 Month Extension Safety and Tolerability Study of SPD489 in the Treatment of Adults With Binge Eating Disorder
Status: Enrolling
Updated: 12/31/1969
Pacific Institute for Research and Evaluation
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Open Label Extension in Adults With Binge Eating Disorder (BED)
A Phase 3, Multicenter, Open-label, 12 Month Extension Safety and Tolerability Study of SPD489 in the Treatment of Adults With Binge Eating Disorder
Status: Enrolling
Updated:  12/31/1969
Brooklyn Medical Institute
mi
from
Brooklyn, NY
Open Label Extension in Adults With Binge Eating Disorder (BED)
A Phase 3, Multicenter, Open-label, 12 Month Extension Safety and Tolerability Study of SPD489 in the Treatment of Adults With Binge Eating Disorder
Status: Enrolling
Updated: 12/31/1969
Brooklyn Medical Institute
mi
from
Brooklyn, NY
Click here to add this to my saved trials
Open Label Extension in Adults With Binge Eating Disorder (BED)
A Phase 3, Multicenter, Open-label, 12 Month Extension Safety and Tolerability Study of SPD489 in the Treatment of Adults With Binge Eating Disorder
Status: Enrolling
Updated:  12/31/1969
Comprehensive Clinical Development
mi
from
Jamaica, NY
Open Label Extension in Adults With Binge Eating Disorder (BED)
A Phase 3, Multicenter, Open-label, 12 Month Extension Safety and Tolerability Study of SPD489 in the Treatment of Adults With Binge Eating Disorder
Status: Enrolling
Updated: 12/31/1969
Comprehensive Clinical Development
mi
from
Jamaica, NY
Click here to add this to my saved trials